INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
PATIENT REVENUES, NET	$ 115,736	$ 117,965	$ 340,366	$ 356,195
OTHER OPERATING INCOME	2,344	9,563	22,212	14,711
EXPENSES:
Operating	95,192	98,706	283,619	289,340
Lease and rent expense	13,263	13,524	39,776	40,560
Professional liability	1,814	2,249	5,381	6,202
General and administrative	7,515	6,487	21,256	20,125
Depreciation and amortization	2,365	2,098	7,034	6,663
Total expenses	120,149	123,064	357,066	362,890
OPERATING (LOSS) INCOME	(2,069)	4,464	5,512	8,016
OTHER INCOME (EXPENSE):
Other income	35	90	248	614
Interest expense, net	(1,104)	(1,172)	(3,213)	(3,841)
Total other expense	(1,069)	(1,082)	(2,965)	(3,227)
(LOSS) INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(3,138)	3,382	2,547	4,789
BENEFIT (PROVISION) FOR INCOME TAXES	279	(209)	(418)	(287)
(LOSS) INCOME FROM CONTINUING OPERATIONS	(2,859)	3,173	2,129	4,502
LOSS FROM DISCONTINUED OPERATIONS:
Operating loss, net of tax benefit	(744)	(374)	(1,350)	(1,004)
NET (LOSS) INCOME	$ (3,603)	$ 2,799	$ 779	$ 3,498
Per common share – basic
Continuing operations (in dollars per share)	$ (0.43)	$ 0.48	$ 0.32	$ 0.68
Discontinued operations (in dollars per share)	(0.11)	(0.06)	(0.20)	(0.15)
Net income (loss) per common share – basic (in dollars per share)	(0.54)	0.42	0.12	0.53
Per common share – diluted
Continuing operations (in dollars per share)	(0.43)	0.48	0.31	0.67
Discontinued operations (in dollars per share)	(0.11)	(0.06)	(0.20)	(0.15)
Net income (loss) per common share – diluted (in dollars per share)	$ (0.54)	$ 0.42	$ 0.11	$ 0.52
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (in shares)	6,643	6,577	6,619	6,606
Diluted (in shares)	6,643	6,626	6,775	6,676